New diabetes clinical trial: Rituximab and Abatacept for Prevention or Reversal of Type 1 Diabetes

Published on: April 29, 2019 at 07:00PM
Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: Rituximab;   Drug: Abatacept
Sponsors:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   National Institutes of Health (NIH);   Juvenile Diabetes Research Foundation
Not yet recruiting